TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
POA Pharma Scandinavia AB
Closing information (x1000 DKK)
Closing information | 2023/09 | 2022/09 | 2021/09 |
Turnover |
61,841
|
57,768
|
57,367 |
Financial expenses |
119
|
16
|
7 |
Earnings before taxes |
960
|
2,684
|
-1,816 |
EBITDA |
1,608
|
3,316
|
-1,360 |
Total assets |
34,265
|
27,789
|
26,687 |
Current assets |
32,771
|
26,068
|
24,299 |
Current liabilities |
16,669
|
9,666
|
9,802 |
Equity capital |
17,596
|
18,123
|
16,885 |
- share capital |
65
|
68
|
73 |
Employees (average) |
13
|
12
|
14 |
Financial ratios
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Solvency |
51.4%
|
65.2%
|
63.3% |
Turnover per employee |
4,757
|
4,814
|
4,098 |
Profit as a percentage of turnover |
1.6%
|
4.6%
|
-3.2% |
Return on assets (ROA) |
3.1%
|
9.7%
|
-6.8% |
Current ratio |
196.6%
|
269.7%
|
247.9% |
Return on equity (ROE) |
5.5%
|
14.8%
|
-10.8% |
Change turnover |
6,812
|
4,166
|
22,771 |
Change turnover % |
12%
|
8%
|
66% |
Chg. No. of employees |
1
|
-2
|
4 |
Chg. No. of employees % |
8%
|
-14%
|
40% |
Total value of public sale
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.